1

INFOSYS.110 BUSINESS SYSTEMS: DELIVERABLE 2: BUSINESS SECTION2014

Name Cameron WinefieldNetID cwin054Group Number: 506Website Link: http://infosys110group506.blogspot.co.nz/

Tutorial DetailsTutor: Day: Time:Kit-Wah Friday 12pm

Time Spent on Assignment: 20 hours Word Count: 1646

2

DELIVERABLE 2: CWIN054INTRODUCTION

In deliverable one we stated that patients are being diagnosed with consequential ailments, that could have been easily averted. Our solution consisted of two principle parts. Part one was a chip that monitored the subject’s key vitals including but not limited to blood pressure, cell count, sugars & fats etc. Part 2 consisted of receiving the raw data & turing it into useable information in real time. Alerts can then be sent to the medical services and arrangements can be made to see the patient.

3. BUSINESS SECTION

3.1 Vision

To increase the world’s quality of life by ridding all illness that can be prevented and

overturned at an early stage of development, using breakthrough technoology as a main

aid.

3.2 Industry Analysis: Medical Monitoring Industry

Industry: Our product falls under the medical monitoring industry.

Force: High/Low: Justification:

Buyer power: High Buyer’s bargaining power would be high as within

the industry there are multiple companies all

offering their services. As noted by Clinton, 2014.

Supplier power: Low Supplier power would also be low as there are

many suppliers who manufactor the materials we

would need. IT parts, a full time monitoring team

etc are both easily interchangable and would

have low switching costs from our point of view.

Thakkar, 2013

2

3

Threat of new entrants: Low Barriers to entry in this industry are high as the

government and patent office, pattent new

medical equiptment and drugs so that other

organisations don’t copy. According to FDA

website, this gives the original company a chance

to recover research, development costs, also

letting them maintain the first mover edge over

rivals. FDA,2012.

Threat of substitutes: Low Low risk for threat of substitutes as currently

other industries provide care when it is to late,

thus being the point of difference to other

competing industries.

Rivalry among existing

competitors:

High The rivalry of competitors in the medical

monitoring industry is high as there are numerous

companies. According to Bird, 2012, giants of the

IT world Google, Microsoft and Apple are all

planning to enter the industry of health

monitoring gadgets, which will only increase the

rivalry.

Overall attractiveness of the industry: Overall there is a high attractiveness to our industry,

low threat of entrants, low threat of substitutes, and low supplier power are all important

items to note. Even though there is high buyer power and high rivalry amoung the industry,

it is important not to be put off as it is quite rare to have all forces classed as low.

3

4

3.3 Customers and Their Needs

Our target market is relatively broad, as everyone has a body, which may not always

function 100% as it should. However, when our product is first launched it will be aimed at

people who are susceptible to illness and people who have a medical history which indicates

they may have health problems in the future. For example people who suffer from genetic

predisposition autoimmune diseases such as diabetes, multiple sclerosis and cardio-vascular

problems.

Their needs are primarily 24 hour a day health monitoring, which is exactly what our

product provides. Jenny Hope states that now every 1 in 7 patients in a hospital bed has

diabetes (2014), our product would not only keep a large number out of the emergency

room by not allowing to get there in the first place, but also free up a lot of beds in hospitals

where bed space is a precious commodity.

3.4 The Product and Service

The product we are offering to these potential customers will satisfy their needs by

providing a sense of security for them. Once our monitoring chip is in the subject’s body,

they are having their vitals monitored, which sends the alerts to our medical team, if there is

any sense of any irregularities or sudden plunges/spikes in many different vitals which are

being measured in real time. Essentially the customer who requires constant care, is now

under constant care, allowing them to live a more routine lifestyle, spending less time

going in and out of hospital.

3.5 Suppliers and Partners

Our first supplier would be an IT/computer firm to supply us with the IT components that

are required, eg the chip itself. Another supplier woud be a medical equiptment company

that manufactors the screens and monitors that can be analysed by our team when the

alerts are sent. A partner we could collaborate with would possibly be local hospitals. An

4

5

ideal place to have our live monitoring centre would be within an existing hospital, it would

create more positions of employment for nurses and doctors to analyse the results.

Hospitals letting us space on their premises would be an ideal partnership. Another

example of a partnership could be national governments. If they liked our product and our

proposal, a subsidy for our product may be considered, this would be another ideal

partnership.

3.6 Strategy: Differentiation

We have chosen to follow the differentiation stratergy for our business . Our product’s

competitive scope will be aimed at a broad market (As mentioned above because the

majority of people alive could bennefit from it) and will also follow a high cost costing

stratergy as it is a product unlike any other on the market today, therefore we are able to

charge monopoly like prices.

Accordingly, our stratergy is Differentiation.

3.7 Value Chain Activity: Technology Development (R&D).

The most important value chain activity for this business is Technology Development

(Research and Development).

With out technology development our product would not be able to go through the

prototype stages into production, also our vision states that we need breakthrough

technology to improve the world’s quality of life. Furthermore, because breakthrough and

new technologies do not come cheaply, our stratergy is differentiation. “Increasing the

world’s quality of” life relates to broad market, “breakthrough technologies” relate to high

cost, equalling differentiation.

3.8 Business Processes

3.8.1. RAW DATA RETRIEVAL PROCESS – The raw data retrieval process is an important

business proces which comes under the technology development (R&D) value chain

heading. The chip records the data and it is sent to the data warehouse where it can be

analysed.

5

6

6

7

3.8.2. PATIENT NOTIFICATION PROCESS- The patient notification process is another

important business process which is placed under the technology development (R&D) value

chain activity. Firstly the anlysis team is sent an alert created by the process above, along

with supporting medical notes and patient history. Next an analysis team member

compares the alert with the supporting documents and makes the decision as to whether

the appropriate people need to be notified. Whether it was a serious alert or not, analysis

program computer adds a brief report as to what happened and then adds it to the

customer record, process complete.

7

8

8

9

3.9 Functionalities

3.9.1. RAW DATA RETRIEVAL PROCESS

Creation of patient file / Acknowledge significant irregularities Update Patient’s file to alert status (Sending of alert)

3.9.2. PATIENT NOTIFICATION PROCESS

Validation and receival of alert Creation of alert report, automatically updates file

3.10 Systems

3.10.1. RECORD MANAGEMENT SYSTEM – The record management system is to do with the

raw data retrieval process and it involves the creation of new customer’s files function.

Using breathrough technology the sytem can create a customer’s file, only relying on the

personal name , importing all the customer’s medical notes and history from their record

held by their GP (& specialisits, surgeons office etc).

3.10.2. DATA ANALYSIS SYSTEM SYSTEM – The data anlysis system is again, to do with the raw

data retrieval process, it determines whether the raw data is out of the norm, when

comparing to the medical notes/history as provided by the record management system

above. It enables the update of the file and the alert sending to analysis team function.

3.10.3. RECORD UPDATE SYTEM - The record update system is under the patient notification

process, it involves and incorporates the alert report/automatic update of the files after the

analysis team have dealt to the alert. This supports our vision by creating an even larger,

more in depth medical database, thus increasing quality of life when the patient requires

medical attention.

9

10

3.11. Summary Table: Value Chain to Systems

Value Chain Activity

Processes Functionalities Specific Information System(s)

Broad Information System(s)

Technologica

l

Development

(R&D)

1. Raw Data Retreival process

1. Acknowledge significant irregularities

2. Update Patient’s file to alert status (Sending of alert)

Record management system

Data Analysis system

Customer relationship management

Decision support system

3. Patient

Notification

process

1. Validation and receival of alert

2. Creation of alert report, automatically updates file

Record update system Customer relationship management

10

11

CONCLUSION

To conclude our product would not be able to take flight if it wasn’t for information systems

and information technology. Our overall business idea was to cut down the number of

terminal illlnesses getting to a point where it was to late for the patient. To many people die

every year just because they did not even know they were sick to begin with. Our product I

believe is a successful attempt at slowing this rate and possibly even halting it. To reiterate,

our vision is to increase the world’s quality of life by ridding all illness that can be prevented

and overturned at an early stage of development, using breakthrough technoology as a

main aid.

REFERENCES

1. Bird, Julie (J.B.). Market for embedded health monitoring-gadgets to hit 170M devices by 2017. Retrieved from http://www.fiercemobilehealthcare.com/story/market-embedded-health-monitoring-gadgets-hit-170m-devices-2017/2012-08-03

2. Clinton, John. (J.C.). Welcome to Medical Alert Systems Ratings. Retrieved from http://www.medicalalertsystemsratings.com/

3. Hope, J. (2014, May 5). One in seven hospital patients is diabetic. The Daily Mail. Retrieved from http://www.dailymail.co.uk/news/article-2620987/One-seven-hospital-patients-diabetic-NHS-pays-record-10billion-year-treat-condition.html

4. Thakkar, Pooja. (P.T.). Top 10 Global Medical Software Providers. Retrieved from http://www.healthcareglobal.com/top_ten/top-10-business/top-10-global-medical-software-providers

5. FDA. (2012, May 12). FAQs on Patents and Exclusivity. Retrieved from http://www.fda.gov/Drugs/DevelopmentApprovalProcess/ucm079031.htm

11